Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy

OBJECTIVES Atrial tachyarrhythmias occur in up to 25% of patients after major thoracic surgery. We examined risk factors for new-onset atrial fibrillation (AF) following oesophagectomy in an attempt to guide prophylactic use of anti-arrhythmic strategies. METHODS Data were extracted from a database...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cardio-thoracic surgery 2012-09, Vol.42 (3), p.438-443
Hauptverfasser: Rao, Vinay P., Addae-Boateng, Emmanuel, Barua, Anupama, Martin-Ucar, Antonio E., Duffy, John P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 443
container_issue 3
container_start_page 438
container_title European journal of cardio-thoracic surgery
container_volume 42
creator Rao, Vinay P.
Addae-Boateng, Emmanuel
Barua, Anupama
Martin-Ucar, Antonio E.
Duffy, John P.
description OBJECTIVES Atrial tachyarrhythmias occur in up to 25% of patients after major thoracic surgery. We examined risk factors for new-onset atrial fibrillation (AF) following oesophagectomy in an attempt to guide prophylactic use of anti-arrhythmic strategies. METHODS Data were extracted from a database of patients who underwent oesophagectomy between 1991 and 2009. Patients with pre-operative arrhythmias were excluded leaving 997 patients for further analysis. Univariate and multivariate logistic regression analyses were performed to identify factors predicting AF, and receiver operating characteristic curves were generated from a model using these predictors. Statistical significance was reflected in a P-value of
doi_str_mv 10.1093/ejcts/ezs085
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1033456872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ejcts/ezs085</oup_id><sourcerecordid>1033456872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-a5adeb7bf9d68b3f646c0decf3ebb81ff433f3f3e1681095f846b0db362f9a7c3</originalsourceid><addsrcrecordid>eNp90MtKxDAUBuAgipfRnWvJRnRhNW3atF0O4g0ENwruykl6MpOxbWrSKuPTG51Rd5JFQvg4l5-Qw5idx6zkF7hQg7_AD8-KbIPsxkXOo5ynz5vhzWIW5WXKdsie9wvGmOBJvk12koSXrCzELlHTGVLoatqhjaBejG_QDVTNsbXDHB30S2o65RA80vBBnfEv1GoKgzPQUG2kM00Dg7Ed1bZp7LvpZtSit_0cZqgG2y73yZaGxuPB-p6Qp-urx8vb6P7h5u5yeh-pNMuHCDKoUeZSl7UoJNciFYrVqDRHKYtY65RzHQ7GogibZ7pIhWS15CLRJeSKT8jpqm7v7OuIfqha4xWG8cJyo69ixnmaiSJPAj1bUeWs9w511TvTglsGVH3FWn3HWq1iDfxoXXmULda_-CfHAI7XALyCRjvolPF_TiQiLUP7CTlZOTv2_7f8BGH6klo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1033456872</pqid></control><display><type>article</type><title>Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rao, Vinay P. ; Addae-Boateng, Emmanuel ; Barua, Anupama ; Martin-Ucar, Antonio E. ; Duffy, John P.</creator><creatorcontrib>Rao, Vinay P. ; Addae-Boateng, Emmanuel ; Barua, Anupama ; Martin-Ucar, Antonio E. ; Duffy, John P.</creatorcontrib><description>OBJECTIVES Atrial tachyarrhythmias occur in up to 25% of patients after major thoracic surgery. We examined risk factors for new-onset atrial fibrillation (AF) following oesophagectomy in an attempt to guide prophylactic use of anti-arrhythmic strategies. METHODS Data were extracted from a database of patients who underwent oesophagectomy between 1991 and 2009. Patients with pre-operative arrhythmias were excluded leaving 997 patients for further analysis. Univariate and multivariate logistic regression analyses were performed to identify factors predicting AF, and receiver operating characteristic curves were generated from a model using these predictors. Statistical significance was reflected in a P-value of &lt;0.05. RESULTS Patients who developed AF (n = 209; 20.96%) were older (median age 70.54 years vs. 66.9 years; P &lt; 0.01) and included 141 males (67.4%) (P = 0.11). Patients with AF were noted to have a higher in-hospital mortality rate (n = 17; 8.1% vs. n = 34; 4.8%) (P = 0.04) and a longer stay in hospital (14 days vs. 12 days; P &lt; 0.01). Multivariate analysis identified advanced age and neo-adjuvant chemotherapy to be independent predictors of the risk of developing AF. Assessment of discriminative ability of a predictive model revealed a c-statistic of just 0.62. CONCLUSIONS Despite the identification of age and neo-adjuvant chemotherapy as predictors of AF, the moderate discriminative ability of predictive modelling does not support the use of prophylactic anti-arrhythmic drugs. However, the high incidence of AF after major thoracic surgery makes it necessary to understand its underlying mechanisms better before prophylactic strategies are considered.</description><identifier>ISSN: 1010-7940</identifier><identifier>EISSN: 1873-734X</identifier><identifier>DOI: 10.1093/ejcts/ezs085</identifier><identifier>PMID: 22390986</identifier><identifier>CODEN: EJCSE7</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Age Factors ; Aged ; Analysis of Variance ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Atrial Fibrillation - etiology ; Atrial Fibrillation - mortality ; Atrial Fibrillation - physiopathology ; Biological and medical sciences ; Cardiac dysrhythmias ; Cardiology. Vascular system ; Databases, Factual ; Esophageal Neoplasms - drug therapy ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - surgery ; Esophagectomy - adverse effects ; Esophagectomy - methods ; Esophagus ; Female ; Follow-Up Studies ; Gastroenterology. Liver. Pancreas. Abdomen ; Heart ; Hospital Mortality - trends ; Humans ; Logistic Models ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Neoadjuvant Therapy - adverse effects ; Neoadjuvant Therapy - methods ; Neoplasm Staging ; Pneumology ; Postoperative Complications - epidemiology ; Postoperative Complications - physiopathology ; Predictive Value of Tests ; Preoperative Care - methods ; Retrospective Studies ; Risk Assessment ; ROC Curve ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Survival Rate ; Treatment Outcome ; Tumors ; United Kingdom</subject><ispartof>European journal of cardio-thoracic surgery, 2012-09, Vol.42 (3), p.438-443</ispartof><rights>The Author 2012. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-a5adeb7bf9d68b3f646c0decf3ebb81ff433f3f3e1681095f846b0db362f9a7c3</citedby><cites>FETCH-LOGICAL-c457t-a5adeb7bf9d68b3f646c0decf3ebb81ff433f3f3e1681095f846b0db362f9a7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26264903$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22390986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rao, Vinay P.</creatorcontrib><creatorcontrib>Addae-Boateng, Emmanuel</creatorcontrib><creatorcontrib>Barua, Anupama</creatorcontrib><creatorcontrib>Martin-Ucar, Antonio E.</creatorcontrib><creatorcontrib>Duffy, John P.</creatorcontrib><title>Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy</title><title>European journal of cardio-thoracic surgery</title><addtitle>Eur J Cardiothorac Surg</addtitle><description>OBJECTIVES Atrial tachyarrhythmias occur in up to 25% of patients after major thoracic surgery. We examined risk factors for new-onset atrial fibrillation (AF) following oesophagectomy in an attempt to guide prophylactic use of anti-arrhythmic strategies. METHODS Data were extracted from a database of patients who underwent oesophagectomy between 1991 and 2009. Patients with pre-operative arrhythmias were excluded leaving 997 patients for further analysis. Univariate and multivariate logistic regression analyses were performed to identify factors predicting AF, and receiver operating characteristic curves were generated from a model using these predictors. Statistical significance was reflected in a P-value of &lt;0.05. RESULTS Patients who developed AF (n = 209; 20.96%) were older (median age 70.54 years vs. 66.9 years; P &lt; 0.01) and included 141 males (67.4%) (P = 0.11). Patients with AF were noted to have a higher in-hospital mortality rate (n = 17; 8.1% vs. n = 34; 4.8%) (P = 0.04) and a longer stay in hospital (14 days vs. 12 days; P &lt; 0.01). Multivariate analysis identified advanced age and neo-adjuvant chemotherapy to be independent predictors of the risk of developing AF. Assessment of discriminative ability of a predictive model revealed a c-statistic of just 0.62. CONCLUSIONS Despite the identification of age and neo-adjuvant chemotherapy as predictors of AF, the moderate discriminative ability of predictive modelling does not support the use of prophylactic anti-arrhythmic drugs. However, the high incidence of AF after major thoracic surgery makes it necessary to understand its underlying mechanisms better before prophylactic strategies are considered.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Analysis of Variance</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Atrial Fibrillation - etiology</subject><subject>Atrial Fibrillation - mortality</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Cardiac dysrhythmias</subject><subject>Cardiology. Vascular system</subject><subject>Databases, Factual</subject><subject>Esophageal Neoplasms - drug therapy</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - surgery</subject><subject>Esophagectomy - adverse effects</subject><subject>Esophagectomy - methods</subject><subject>Esophagus</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Heart</subject><subject>Hospital Mortality - trends</subject><subject>Humans</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Neoadjuvant Therapy - adverse effects</subject><subject>Neoadjuvant Therapy - methods</subject><subject>Neoplasm Staging</subject><subject>Pneumology</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - physiopathology</subject><subject>Predictive Value of Tests</subject><subject>Preoperative Care - methods</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>ROC Curve</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>United Kingdom</subject><issn>1010-7940</issn><issn>1873-734X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90MtKxDAUBuAgipfRnWvJRnRhNW3atF0O4g0ENwruykl6MpOxbWrSKuPTG51Rd5JFQvg4l5-Qw5idx6zkF7hQg7_AD8-KbIPsxkXOo5ynz5vhzWIW5WXKdsie9wvGmOBJvk12koSXrCzELlHTGVLoatqhjaBejG_QDVTNsbXDHB30S2o65RA80vBBnfEv1GoKgzPQUG2kM00Dg7Ed1bZp7LvpZtSit_0cZqgG2y73yZaGxuPB-p6Qp-urx8vb6P7h5u5yeh-pNMuHCDKoUeZSl7UoJNciFYrVqDRHKYtY65RzHQ7GogibZ7pIhWS15CLRJeSKT8jpqm7v7OuIfqha4xWG8cJyo69ixnmaiSJPAj1bUeWs9w511TvTglsGVH3FWn3HWq1iDfxoXXmULda_-CfHAI7XALyCRjvolPF_TiQiLUP7CTlZOTv2_7f8BGH6klo</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Rao, Vinay P.</creator><creator>Addae-Boateng, Emmanuel</creator><creator>Barua, Anupama</creator><creator>Martin-Ucar, Antonio E.</creator><creator>Duffy, John P.</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120901</creationdate><title>Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy</title><author>Rao, Vinay P. ; Addae-Boateng, Emmanuel ; Barua, Anupama ; Martin-Ucar, Antonio E. ; Duffy, John P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-a5adeb7bf9d68b3f646c0decf3ebb81ff433f3f3e1681095f846b0db362f9a7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Analysis of Variance</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Atrial Fibrillation - etiology</topic><topic>Atrial Fibrillation - mortality</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Cardiac dysrhythmias</topic><topic>Cardiology. Vascular system</topic><topic>Databases, Factual</topic><topic>Esophageal Neoplasms - drug therapy</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - surgery</topic><topic>Esophagectomy - adverse effects</topic><topic>Esophagectomy - methods</topic><topic>Esophagus</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Heart</topic><topic>Hospital Mortality - trends</topic><topic>Humans</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Neoadjuvant Therapy - adverse effects</topic><topic>Neoadjuvant Therapy - methods</topic><topic>Neoplasm Staging</topic><topic>Pneumology</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - physiopathology</topic><topic>Predictive Value of Tests</topic><topic>Preoperative Care - methods</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>ROC Curve</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rao, Vinay P.</creatorcontrib><creatorcontrib>Addae-Boateng, Emmanuel</creatorcontrib><creatorcontrib>Barua, Anupama</creatorcontrib><creatorcontrib>Martin-Ucar, Antonio E.</creatorcontrib><creatorcontrib>Duffy, John P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cardio-thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rao, Vinay P.</au><au>Addae-Boateng, Emmanuel</au><au>Barua, Anupama</au><au>Martin-Ucar, Antonio E.</au><au>Duffy, John P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy</atitle><jtitle>European journal of cardio-thoracic surgery</jtitle><addtitle>Eur J Cardiothorac Surg</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>42</volume><issue>3</issue><spage>438</spage><epage>443</epage><pages>438-443</pages><issn>1010-7940</issn><eissn>1873-734X</eissn><coden>EJCSE7</coden><abstract>OBJECTIVES Atrial tachyarrhythmias occur in up to 25% of patients after major thoracic surgery. We examined risk factors for new-onset atrial fibrillation (AF) following oesophagectomy in an attempt to guide prophylactic use of anti-arrhythmic strategies. METHODS Data were extracted from a database of patients who underwent oesophagectomy between 1991 and 2009. Patients with pre-operative arrhythmias were excluded leaving 997 patients for further analysis. Univariate and multivariate logistic regression analyses were performed to identify factors predicting AF, and receiver operating characteristic curves were generated from a model using these predictors. Statistical significance was reflected in a P-value of &lt;0.05. RESULTS Patients who developed AF (n = 209; 20.96%) were older (median age 70.54 years vs. 66.9 years; P &lt; 0.01) and included 141 males (67.4%) (P = 0.11). Patients with AF were noted to have a higher in-hospital mortality rate (n = 17; 8.1% vs. n = 34; 4.8%) (P = 0.04) and a longer stay in hospital (14 days vs. 12 days; P &lt; 0.01). Multivariate analysis identified advanced age and neo-adjuvant chemotherapy to be independent predictors of the risk of developing AF. Assessment of discriminative ability of a predictive model revealed a c-statistic of just 0.62. CONCLUSIONS Despite the identification of age and neo-adjuvant chemotherapy as predictors of AF, the moderate discriminative ability of predictive modelling does not support the use of prophylactic anti-arrhythmic drugs. However, the high incidence of AF after major thoracic surgery makes it necessary to understand its underlying mechanisms better before prophylactic strategies are considered.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>22390986</pmid><doi>10.1093/ejcts/ezs085</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1010-7940
ispartof European journal of cardio-thoracic surgery, 2012-09, Vol.42 (3), p.438-443
issn 1010-7940
1873-734X
language eng
recordid cdi_proquest_miscellaneous_1033456872
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Age Factors
Aged
Analysis of Variance
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Atrial Fibrillation - etiology
Atrial Fibrillation - mortality
Atrial Fibrillation - physiopathology
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Databases, Factual
Esophageal Neoplasms - drug therapy
Esophageal Neoplasms - pathology
Esophageal Neoplasms - surgery
Esophagectomy - adverse effects
Esophagectomy - methods
Esophagus
Female
Follow-Up Studies
Gastroenterology. Liver. Pancreas. Abdomen
Heart
Hospital Mortality - trends
Humans
Logistic Models
Male
Medical sciences
Middle Aged
Multivariate Analysis
Neoadjuvant Therapy - adverse effects
Neoadjuvant Therapy - methods
Neoplasm Staging
Pneumology
Postoperative Complications - epidemiology
Postoperative Complications - physiopathology
Predictive Value of Tests
Preoperative Care - methods
Retrospective Studies
Risk Assessment
ROC Curve
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Survival Rate
Treatment Outcome
Tumors
United Kingdom
title Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T23%3A16%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age%20and%20neo-adjuvant%20chemotherapy%20increase%20the%20risk%20of%20atrial%20fibrillation%20following%20oesophagectomy&rft.jtitle=European%20journal%20of%20cardio-thoracic%20surgery&rft.au=Rao,%20Vinay%20P.&rft.date=2012-09-01&rft.volume=42&rft.issue=3&rft.spage=438&rft.epage=443&rft.pages=438-443&rft.issn=1010-7940&rft.eissn=1873-734X&rft.coden=EJCSE7&rft_id=info:doi/10.1093/ejcts/ezs085&rft_dat=%3Cproquest_cross%3E1033456872%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1033456872&rft_id=info:pmid/22390986&rft_oup_id=10.1093/ejcts/ezs085&rfr_iscdi=true